Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Reprod Med ; 51(9): 715-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17039701

ABSTRACT

BACKGROUND: Benign metastasizing leiomyoma (BML) of the lung is a rare manifestation of metastasis from a uterine myoma, in which its benign characteristics are maintained. The majority of cases are asymptomatic. CASES: Case 1 responded to the classic treatment of oophorectomy, after which an improvement in symptoms was achieved. In case 2, however, symptoms appeared following oophorectomy and were treated with raloxifene. CONCLUSION: These cases show the uncertainty that exists with respect to the evolution and treatment of symptomatic BML. Raloxifene is a therapeutic agent that has not been widely studied for this purpose but should be considered for inclusion in the arsenal of therapeutic options available.


Subject(s)
Leiomyomatosis/pathology , Lung Neoplasms/secondary , Lung/pathology , Myometrium/pathology , Uterine Neoplasms/pathology , Adult , Estrogen Antagonists/therapeutic use , Female , Humans , Leiomyomatosis/drug therapy , Leiomyomatosis/surgery , Lung Neoplasms/drug therapy , Lung Neoplasms/surgery , Middle Aged , Ovariectomy , Raloxifene Hydrochloride/therapeutic use , Treatment Outcome
2.
Contraception ; 73(6): 634-40, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16730498

ABSTRACT

OBJECTIVE: This descriptive study evaluated endometrial histology, microvascular density and caliber, and quantification of matrix metalloproteinase (MMP-3) expression in long-term users of the Nestorone (NES)-releasing implant who presented or not endometrial breakthrough bleeding (BTB). METHODS: Endometrial biopsies were obtained from 32 healthy women with unpredictable BTB. The quantitative analysis was performed only in 20 samples. RESULTS: The mean duration of use of the implant among the 14 women with BTB was 19.6+/-1.0 months, and the other six women had used the implant for 17.7+/-2.3 months (mean+/-S.E.M.). Histological analysis of the endometrial tissue showed a predominance of progestogenic pattern followed by atrophic and proliferative endometrium in both groups. Mucosal breakdown and glandular pseudostratification were observed in half of the cases. Endometrial vascular density was 73.1+/-10.0 and 57.5+/-24.1 vessels/mm(2), and maximum vessel diameter was 923.3+/-86.0 and 1038.0+/-404 microm (mean+/-S.E.M.) in the group with and without BTB, respectively, without significance, and the rate of cells expressing MMP-3x1000 counted stromal cells was 155.8+/-24.8 and 127.0+/-19.0 (mean+/-S.E.M.) in both groups, respectively, without significance. CONCLUSIONS: This study provides information about some endometrial aspects of women using NES in contraceptive implants. In addition, the endometrium was similar during long-term use of NES-releasing contraceptive implants in women with and without endometrial bleeding.


Subject(s)
Endometrium/pathology , Matrix Metalloproteinase 3/analysis , Metrorrhagia , Norprogesterones/adverse effects , Adult , Biopsy , Contraceptive Agents, Female/adverse effects , Drug Implants/adverse effects , Endometrium/blood supply , Endometrium/drug effects , Endometrium/enzymology , Female , Humans , Metrorrhagia/chemically induced , Microcirculation/drug effects , Norprogesterones/administration & dosage
3.
Hum Reprod ; 19(8): 1778-84, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15192067

ABSTRACT

BACKGROUND: The main reason for discontinuation of the levonorgestrel-releasing intrauterine system (LNG-IUS) is unpredictable bleeding pattern. METHODS: The objective of the study was to evaluate the endometrial histology, microvascular density and calibre, and the quantification of matrix metalloproteinase (MMP-3) in long-term users of LNG-IUS, with and without bleeding. Endometrial biopsies were obtained from 58 healthy women, 29 who maintained some degree of endometrial bleeding and 29 who were amenorrhoeic. RESULTS: In the histological analysis, the majority of samples displayed a progestin-modified appearance. The major glandular diameter and the perimeter were significantly greater in the group of women with amenorrhoea. A significantly higher number of leukocytes was found in the group with bleeding (P = 0.014). No significant correlation was observed between the microvascular density or calibre and the bleeding pattern. MMP-3 showed a significantly higher number of reactive cells (P = 0.005) in the group who maintained some degree of bleeding. CONCLUSIONS: Women using LNG-IUS who maintained endometrial bleeding during its use presented a higher number of leukocytes and MMP-3 in the endometrium when compared to women using LNG-IUS who became amenorrhoeic. However, the results did not provide evidence for microvascular pattern changes.


Subject(s)
Amenorrhea/pathology , Contraceptive Agents, Female/adverse effects , Endometrium/pathology , Levonorgestrel/adverse effects , Matrix Metalloproteinase 3/metabolism , Menstruation/drug effects , Adult , Amenorrhea/metabolism , Biopsy , Contraceptive Agents, Female/administration & dosage , Endometrium/blood supply , Endometrium/enzymology , Female , Humans , Leukocytes/pathology , Levonorgestrel/administration & dosage , Microcirculation/drug effects , Microcirculation/pathology , Stromal Cells/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...